Baker Bros. Advisors reports acquisition of $35.02 million in Madrigal Pharmaceuticals shares
MDGL•Baker Bros. Advisors reported purchasing 91,806 Madrigal Pharmaceuticals shares, increasing its indirectly held position to 2,040,682 shares.
1. Share purchases disclosed
Baker Bros. Advisors reported purchases of 91,806 Madrigal Pharmaceuticals common shares in a beneficial ownership filing, bringing its reported indirectly held position to 2,040,682 shares.
